| Product Code: ETC7906131 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Blockbuster Oncology Brands Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Blockbuster Oncology Brands Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Blockbuster Oncology Brands Market - Industry Life Cycle |
3.4 Latvia Blockbuster Oncology Brands Market - Porter's Five Forces |
3.5 Latvia Blockbuster Oncology Brands Market Revenues & Volume Share, By Brands, 2021 & 2031F |
3.6 Latvia Blockbuster Oncology Brands Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Latvia Blockbuster Oncology Brands Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Latvia |
4.2.2 Advancements in oncology research and development |
4.2.3 Growing investments in healthcare infrastructure and oncology treatments |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for oncology drugs |
4.3.2 High costs associated with blockbuster oncology brands |
4.3.3 Limited access to specialized oncology care in certain regions of Latvia |
5 Latvia Blockbuster Oncology Brands Market Trends |
6 Latvia Blockbuster Oncology Brands Market, By Types |
6.1 Latvia Blockbuster Oncology Brands Market, By Brands |
6.1.1 Overview and Analysis |
6.1.2 Latvia Blockbuster Oncology Brands Market Revenues & Volume, By Brands, 2021- 2031F |
6.1.3 Latvia Blockbuster Oncology Brands Market Revenues & Volume, By Opdivo, 2021- 2031F |
6.1.4 Latvia Blockbuster Oncology Brands Market Revenues & Volume, By Keytruda, 2021- 2031F |
6.1.5 Latvia Blockbuster Oncology Brands Market Revenues & Volume, By Perjeta, 2021- 2031F |
6.1.6 Latvia Blockbuster Oncology Brands Market Revenues & Volume, By Ibrance, 2021- 2031F |
6.1.7 Latvia Blockbuster Oncology Brands Market Revenues & Volume, By Tecentriq, 2021- 2031F |
6.1.8 Latvia Blockbuster Oncology Brands Market Revenues & Volume, By Gazyva, 2021- 2031F |
6.1.9 Latvia Blockbuster Oncology Brands Market Revenues & Volume, By Darzalex, 2021- 2031F |
6.1.10 Latvia Blockbuster Oncology Brands Market Revenues & Volume, By Darzalex, 2021- 2031F |
6.2 Latvia Blockbuster Oncology Brands Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Latvia Blockbuster Oncology Brands Market Revenues & Volume, By Lung cancer, 2021- 2031F |
6.2.3 Latvia Blockbuster Oncology Brands Market Revenues & Volume, By Breast cancer, 2021- 2031F |
6.2.4 Latvia Blockbuster Oncology Brands Market Revenues & Volume, By Multiple myeloma, 2021- 2031F |
6.2.5 Latvia Blockbuster Oncology Brands Market Revenues & Volume, By Lymphoma, 2021- 2031F |
6.2.6 Latvia Blockbuster Oncology Brands Market Revenues & Volume, By Others, 2021- 2031F |
7 Latvia Blockbuster Oncology Brands Market Import-Export Trade Statistics |
7.1 Latvia Blockbuster Oncology Brands Market Export to Major Countries |
7.2 Latvia Blockbuster Oncology Brands Market Imports from Major Countries |
8 Latvia Blockbuster Oncology Brands Market Key Performance Indicators |
8.1 Percentage of oncology drug approvals in Latvia |
8.2 Number of clinical trials for blockbuster oncology brands conducted in Latvia |
8.3 Patient survival rates and quality of life improvements due to blockbuster oncology treatments |
8.4 Rate of adoption of innovative oncology therapies in Latvia |
8.5 Number of partnerships and collaborations between pharmaceutical companies and healthcare providers in Latvia |
9 Latvia Blockbuster Oncology Brands Market - Opportunity Assessment |
9.1 Latvia Blockbuster Oncology Brands Market Opportunity Assessment, By Brands, 2021 & 2031F |
9.2 Latvia Blockbuster Oncology Brands Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Latvia Blockbuster Oncology Brands Market - Competitive Landscape |
10.1 Latvia Blockbuster Oncology Brands Market Revenue Share, By Companies, 2024 |
10.2 Latvia Blockbuster Oncology Brands Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here